SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001718111-20-000002
Filing Date
2020-05-22
Accepted
2020-05-22 06:46:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 13DA.htm SC 13D/A 60052
  Complete submission text file 0001718111-20-000002.txt   61733
Mailing Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059
Business Address 184 LIBERTY CORNER ROAD, SUITE 302 WARREN NJ 07059 908-574-4770
Bellerophon Therapeutics, Inc. (Subject) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88741 | Film No.: 20903591
SIC: 2834 Pharmaceutical Preparations

Mailing Address 950 THIRD AVENUE 25TH FL NEW YORK NY 10022
Business Address 950 THIRD AVENUE 25TH FL NEW YORK NY 10022 212-878-3702
Puissance Cross-Border Opportunities III LLC (Filed by) CIK: 0001718111 (see all company filings)

IRS No.: 611853871 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 6799 Investors, NEC